SQUAWK/NEWS
Menu
Live News EQUITY L impact

Dyne Therapeutics Files SEC Form

Dyne Therapeutics submits regulatory filing with the SEC. The filing is available for public review.

DYNE

Filed: 2026-05-28 AccNo: 0001193125-26-245237 Size: 4 KB